The group's principal activities include developing, manufacturing and marketing medical diagnostic equipment to the vision care marketplace. The products of the group include ARIS (automated retinal imaging system), cataract imaging device, a pre-programmed visual stimuli system for screening, diagnosis and monitoring of conditions that affect neural pathways, and a blood glucose concentration monitoring device for diabetic patients. The group operates from Arizona, United States.